Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebocontrolled, phase 3 trial - Shitara, K; Doi, T; Dvorkin, M (Lancet Oncol, 2018)
et al.